PL172724B1 - i sposób wytwarzania doustnego systemu terapeutycznego PL PL PL - Google Patents

i sposób wytwarzania doustnego systemu terapeutycznego PL PL PL

Info

Publication number
PL172724B1
PL172724B1 PL93307050A PL30705093A PL172724B1 PL 172724 B1 PL172724 B1 PL 172724B1 PL 93307050 A PL93307050 A PL 93307050A PL 30705093 A PL30705093 A PL 30705093A PL 172724 B1 PL172724 B1 PL 172724B1
Authority
PL
Poland
Prior art keywords
cross
drug
polymer
matrix
hydrogel
Prior art date
Application number
PL93307050A
Other languages
English (en)
Polish (pl)
Other versions
PL307050A1 (en
Inventor
Helle Brondsted
Lars Hovgaard
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PL307050A1 publication Critical patent/PL307050A1/xx
Publication of PL172724B1 publication Critical patent/PL172724B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Retarders (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL93307050A 1992-07-07 1993-07-06 i sposób wytwarzania doustnego systemu terapeutycznego PL PL PL PL172724B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK92895A DK89592D0 (da) 1992-07-07 1992-07-07 Laegemiddelafgivelsesindretning samt fremgangsmaade til fremstilling deraf
PCT/DK1993/000227 WO1994001136A1 (en) 1992-07-07 1993-07-06 A drug delivery device and a method of making such device

Publications (2)

Publication Number Publication Date
PL307050A1 PL307050A1 (en) 1995-05-02
PL172724B1 true PL172724B1 (pl) 1997-11-28

Family

ID=8098759

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93307050A PL172724B1 (pl) 1992-07-07 1993-07-06 i sposób wytwarzania doustnego systemu terapeutycznego PL PL PL

Country Status (15)

Country Link
EP (1) EP0648129A1 (cs)
JP (1) JPH07508735A (cs)
KR (1) KR950702437A (cs)
AU (1) AU671651B2 (cs)
BR (1) BR9306700A (cs)
CA (1) CA2139747A1 (cs)
CZ (1) CZ3895A3 (cs)
DK (1) DK89592D0 (cs)
FI (1) FI950065A7 (cs)
HU (1) HUT75665A (cs)
NZ (1) NZ253678A (cs)
PL (1) PL172724B1 (cs)
RU (1) RU2139093C1 (cs)
SK (1) SK1795A3 (cs)
WO (1) WO1994001136A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
ES2198579T3 (es) * 1996-07-01 2004-02-01 Universiteit Utrecht Hidrogeles hidrolizables para liberacion controlada.
CN1402629A (zh) 1999-12-23 2003-03-12 辉瑞产品公司 提供提高的药物浓度的药物组合物
JP2013523748A (ja) * 2010-03-29 2013-06-17 サーモディクス，インコーポレイテッド 注射用薬物送達製剤
JP6199883B2 (ja) 2011-12-05 2017-09-20 インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ 医療用オルガノゲルプロセス及び組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2550750A (en) * 1947-09-22 1951-05-01 Arthur C Abelt Differential for automobiles
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
JPS57500432A (cs) * 1980-03-20 1982-03-11
IT1131833B (it) * 1980-06-20 1986-06-25 Crinos Industria Farmaco Eccipienti per sostanze spermicide
JPS5997346A (ja) * 1982-11-24 1984-06-05 Komatsu Ltd 車両のデイフアレンシヤル装置
US4925677A (en) * 1988-08-31 1990-05-15 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
SE9002339L (sv) * 1990-07-04 1992-01-05 Kabi Pharmacia Ab Terapeutisk komposition och foerfarande foer dess framstaellning

Also Published As

Publication number Publication date
PL307050A1 (en) 1995-05-02
DK89592D0 (da) 1992-07-07
FI950065A0 (fi) 1995-01-05
HUT75665A (en) 1997-05-28
FI950065A7 (fi) 1995-03-02
WO1994001136A1 (en) 1994-01-20
NZ253678A (en) 1996-07-26
JPH07508735A (ja) 1995-09-28
BR9306700A (pt) 1998-12-08
CA2139747A1 (en) 1994-01-20
EP0648129A1 (en) 1995-04-19
SK1795A3 (en) 1995-09-13
HU9500042D0 (en) 1995-03-28
CZ3895A3 (en) 1995-09-13
KR950702437A (ko) 1995-07-29
AU4417893A (en) 1994-01-31
AU671651B2 (en) 1996-09-05
RU2139093C1 (ru) 1999-10-10

Similar Documents

Publication Publication Date Title
RU2093148C1 (ru) Композиции с замедленным (пролонгированным) высвобождением
Rubinstein Approaches and opportunities in colon-specific drug delivery
US6284273B1 (en) Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
HU210497B (en) Process for production of modified pectin
KR20010074641A (ko) 다당류를 이용한 대장선택성 약물전달 조성물 및 약학제제
Bourgeois et al. Polymer colon drug delivery systems and their application to peptides, proteins, and nucleic acids
US5342624A (en) Dispensing device
US20240082168A1 (en) Controlled drug release formulation
PL172724B1 (pl) i sposób wytwarzania doustnego systemu terapeutycznego PL PL PL
Leopold A Practical Approach in the Design of Colon‐specific Drug Delivery Systems
Bajpai et al. Dynamic release of riboflavin from a colon-targeted delivery device: an in vitro study
Shah et al. DEVELOPMENTS IN COLON SPECIFIC DRUG DELIVERY SYSTEMS-A REVIEW.
Bajpai et al. Ionotropically crosslinked pectinate-based systems for drug delivery
Kumar et al. Alginate Hydrogels as a Colon-Targeted Drug Delivery System
Kaur et al. Recent approaches for colon drug delivery
Swain et al. Recent advances in colon-specific drug delivery systems
Sharma et al. Various Approaches Used For Colonic Drug Delivery System
CN118236318A (zh) 一种单向缓释化疗药物的放疗隔离水凝胶系统及制备方法
rights are reserved by Nalanda et al. Review on Recent and Novel Approaches to Colon Targeted Drug Delivery Systems
Prashar et al. Asian Journal of Biochemical and Pharmaceutical Research
Garapati et al. Tailoring the Release of Drugs Using Excipients
Ofori-Kwakye Studies on the use of mixed films for bimodal drug delivery
Bhattacharjee Colon-specific release of Metronidazole from tablets compression-coated
JPH01224311A (ja) 胃内滞留生の浮遊顆粒の製法
Kirtania et al. Drug targeting towards colon using natural polymers: Research trends in the last decade